Glenmark Pharmaceuticals Ltd
BSE:
NSE:GLENMARK
GLENMARK Share Price
BSE:
NSE:GLENMARK
Pharmaceuticals
Large Cap
₹-
0 (0%)
Market Cap
₹42,750.09Cr
Glenmark Pharmaceuticals Ltd Performance
▲
▲
▲
▲
Glenmark Pharmaceuticals Ltd Fundamentals
Glenmark Pharmaceuticals Ltd Futures
| Monthly Contracts | Days For Expiry | Last Traded Price | Volume |
|---|---|---|---|
| Glenmark Pharmaceuticals Ltd 30 Jan 2025 | 15 | 1466.25 | 4451 |
| Glenmark Pharmaceuticals Ltd 27 Feb 2025 | 43 | 1474.9 | 269 |
| Glenmark Pharmaceuticals Ltd 27 Mar 2025 | 71 | 1485.6 | 2 |
Glenmark Pharmaceuticals Ltd Options Snapshot
Glenmark Pharmaceuticals Ltd Delivery and Volume
About Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical product
| Name | Designation |
|---|---|
| Glenn Saldanha | Chairman & Managing Director |
| Gracias Saldanha | Chairman |
| Cheryl Pinto | Executive Director (Corporate) |
| V S Mani | Executive Director & Group CFO |
| B E Saldanha | Non Executive Director |
| Julio F Ribeiro | Director |
| Natvarlal B Desai | Director |
| Rajesh Desai. | Independent Non Exe. Director |
| M Gopal Krishnan | Director |
| Sridhar Gorthi | Director |
| Sona Saira Ramasastry | Independent Non Exe. Director |
| A S Mohanty | Director |
| M J Mendonza | Company Secretary |
| Dipankar Bhattacharjee | Independent Non Exe. Director |
| Sanjay Chowdhary | Joint Company Secretary |
| V R Iyer | Independent Non Exe. Director |
| D R Mehta | Additional Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Glenmark Pharmaceuticals Ltd FAQs
How do I Buy Glenmark Pharmaceuticals Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Glenmark Pharmaceuticals Ltd shares in BlinkX.
What is the Share Price of Glenmark Pharmaceuticals Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Glenmark Pharmaceuticals Ltd's share price is ₹1463.3 as of 2025-01-15.
What is the PE ratio of Glenmark Pharmaceuticals Ltd?
Glenmark Pharmaceuticals Ltd's P/E ratio is - times as of 2025-01-15.
What is the PB ratio of Glenmark Pharmaceuticals Ltd?
Glenmark Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 5.06, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Glenmark Pharmaceuticals Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Glenmark Pharmaceuticals Ltd's market capitalization is ₹42750.09 Cr as on 2025-01-15.
What is the ROE of Glenmark Pharmaceuticals Ltd?
The current financial records of Glenmark Pharmaceuticals Ltd show a 6.98% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Glenmark Pharmaceuticals Ltd?
According to Glenmark Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹5157.09, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Glenmark Pharmaceuticals Ltd?
The 52-week high/low price of a Glenmark Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Glenmark Pharmaceuticals Ltd's 52-week high and low as of 2025-01-15 are ₹1540 and ₹1453, respectively.
